Newsfeeds - Spark Newswire

1 minute read

HC Wainwright & Co. Initiates Coverage On Virios Therapeutics with Buy Rating, Announces Price Target of $12

Today, 4:03 AM

HC Wainwright & Co. analyst Sean Lee initiates coverage on Virios Therapeutics (NASDAQ:VIRI) with a Buy rating and announces Price Target of $12.

VIRI

1 minute read

Virios Therapeutics Q3 EPS $(0.49) Beats $(0.69) Estimate

By Bill Haddad

Today, 4:03 AM

Virios Therapeutics (NASDAQ:VIRI) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.69) by 28.99 percent.

VIRI

10 minute read

Earnings Scheduled For November 11, 2021

By Benzinga Insights

Today, 4:03 AM

Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million.

ACHR

5 minute read

64 Biggest Movers From Yesterday

By Lisa Levin

Today, 4:03 AM

Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the company filed a mixed shelf offering on Friday after the close.

ABVC

11 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 4:03 AM

On Friday morning, 155 companies achieved new lows for the year.

AAU

1 minute read

News

Virios Therapeutics CEO Highlights Novel Therapeutic Approach for Treating Fibromyalgia and Irritable Bowel Syndrome in Stock News Now Video Interview

By Benzinga Newsdesk

Today, 4:03 AM

Virios Therapeutics, Inc. (Nasdaq: VIRI), a clinical-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, announced today that Chairman and CEO, Greg Duncan,

VIRI

5 minute read

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma

By Shanthi Rexaline

Today, 4:03 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11)

ABCL

1 minute read

Virios Therapeutics Q2 EPS $(0.51) Beats $(0.57) Estimate

By Benzinga Newsdesk

Today, 4:03 AM

Virios Therapeutics (NASDAQ:VIRI) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.57) by 10.53 percent.

VIRI

15 minute read

Earnings Scheduled For August 12, 2021

By Benzinga Insights

Today, 4:03 AM

Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.

AACG

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 4:03 AM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL